Favrille Cancer Product Receives Fast Track Status
13th Jan 2006, 23:22 GMT
FavId, an investigational treatment for non-Hodgkin's lymphoma produced by biotech company Favrille, has been granted fast track designation by the FDA. The B-cell follicular non-Hodgkin's lymphoma (NHL) treatment is Favrille's lead product candidate for this disease.
Favrille Cancer Product Receives Fast Track Status related news:
- Favrille Gets FDA FavId Fast Track — Pharmaceuticals News from StratCenter.com
- Favrille lymphoma drug fast tracked — United Press International - Health Business
- Favrille Receives FDA Fast Track Designation for FavId, Lead Product Candidate for Follicular B-Cell Non-Hodgkin's Lymphoma — PR Newswire: All Releases
- Favrille Gets FDA FavId Fast Track and Keygene Selects 454 Life Sciences' Novel Sequencing Technology to Enable Large-Scale SNP Discovery and Detection in Higher Eukaryotic Organisms — Financial News USA (OTC: FNWU)
- Fast Track Cancer Drug Approval Call — Health news @ FemaleFirst Health
- Fast Track Systems: Fast Track Achieves Registered CDISC Solution Provider Status — Market Wire - Pharmaceuticals and Biotech
- FDA Grants Accelerated Review Of Microbicide Developed By Australian Pharmaceutical Company — Medical News Today RSS/XML Feed
- Starpharma's HIV Drug Fast Tracked By FDA — RedOrbit News - Health
- Gay rights bill on fast track — Seattle Post-Intelligencer: Local News
- pulsescp Receives Product of the Year Award — PR Web (The Free Wire Service) Technology Telecommunications
Latest news from RedOrbit News - Health:
- Pet Shop Boys Fans Know Better _ Why Bother Sharing?
- Corcept Tests Psych. Major Depression Rx
- On Its 30th Anniversary, Smokeout Provides Even More Help Quitting Smoking
- Health Plans and Disease Management Companies Are Seeking To Reduce the Use of the ER for Non-Urgent Care - Urgent Emergency Room Usage October 18, 2006 Audio Conference on CD-ROM
- Invitation Conference Call Analyst Meeting
- As Benefit Costs Rise, Employee Retirement Savings Decline
- Aetna to Help Members Quit Tobacco With New Tobacco Cessation Program
- Lilly: Arxxant Cuts Sight Loss in Diabetes
- SW Doctors PA Launch Affordable Primary Care (APC) Services
- Health Savings Technology Appoints New Management Team to Spearhead Growth in Customer-Directed Healthcare Industry